Last year, autism activist Ivan Corea was in London, interviewed by CNN and GMTV for the first introduction.. The economic crisis and the recession in , the charity sector has devastated by a huge drop in donations for charity. The Foundation hopes to in their hearts in their hearts to give and support the work of UKAF. The charity is lobbying and campaigns especially on behalf of the poor. Last yearcalled Prime Minister Gordon Brown and Chancellor Alistair Darling, the tax credits under the Disability Living Allowance and Attendance Allowance in the 2009 budget to increase in April, so that parents, carers, children and adults with autism and Asperger syndrome cope with the economic crisis and deepening recession.
Ahmed said that, these studies suggest that EGCG or molecules that could be derived synthetically from the EGCG found in green tea is of therapeutic value in inhibiting the joint destruction in this challenging disease. The laboratory focused now on the inhibitory role of EGCG in gene expression. The scientists plan to give EGCG orally to mice bred to genetically to see animal models of rheumatoid arthritis, whether similar therapeutic similar therapeutic or preventive effects. Ahmed believes that these studies form for future testing for future testing of green tea compounds in humans with rheumatoid arthritis.
Scientist Dr. That suppressed to cartilage, bone Destruction In Arthritis Green Tea CompoundIn rheumatoid arthritis a person immune system immune system, the joints by activating the synovial tissue that lines the body moving joints, inflammation, swelling, pain and eventually erosion of the bone and cartilage, and deformation of the joint.In clinical development and two in late preclinical developing.. Over Action Pharma A / S. Action Pharma is a privately run Danish biotechnology companies , the primary strategy which ActionScript Pharma is development of novel drug candidates targeted melanocortin receptors and to bring the for to develop clinical proof of concept for the later partnerships. DPP – product candidates have at first in his class and use novel mechanism of profiles to efficiency is superior compared with the current market.
It also develops Action Pharma AP1189 is for oral administration for oral administration aligned for treating systemic inflammatory disorders such as rheumatoid arthritis inflammatory bowel disease. Similar AP405 being developed for the topical treatment of inflammatory skin diseases such atopic dermatitis.